Nordic walking for cardiovascular prevention in patients with ischaemic heart disease or metabolic syndrome

被引:4
|
作者
Vehi, Cristina [1 ]
Falces, Carles [1 ]
Angel Sarlat, Miquel [2 ]
Gonzalo, Ana [3 ]
Andrea, Rut [1 ]
Sitges, Marta [1 ]
机构
[1] Univ Barcelona, Inst Cardiovasc, Hosp Clin, Serv Cardiol, Barcelona, Spain
[2] Ctr Atencio Primaria Bordeta Magoria, Inst Catala Salut, Barcelona, Spain
[3] Ctr Atencio Primaria La Marina, Inst Catala Salut, Barcelona, Spain
来源
MEDICINA CLINICA | 2016年 / 147卷 / 12期
关键词
Nordic walking; Ischaemic heart disease; Prevention; Rehabilitation; SECONDARY PREVENTION; PHYSICAL-ACTIVITY;
D O I
10.1016/j.medcli.2016.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: The incidence of atherosclerotic diseases has increased in Europe due in part to the population's sedentary lifestyle. Physical activity is useful for cardiovascular prevention. Nordic walking (NW) mobilizes a great number of muscular groups and is very popular in northern Europe. There is no data available on its impact in the healthcare system of the Mediterranean area. We propose the implementation of a NW program to promote physical activity and control cardiovascular risk factors (CVRF), as well as to improve quality of life and the adherence to medical treatment in patients with a chronic ischemic heart disease or metabolic syndrome. Methods: We selected patients with uncontrolled CVRFs. These patients performed 2 weekly sessions of NW over the course of one year. Baseline data extracted from the patients' medical history, quality of life questionnaires and on adherence to treatment was compared with the results obtained at the end of the program. Results:. A reduction in the rate of CVRFs from 4.78 to 3 was observed, with an evident trend towards the improvement of the patients' quality of life and a better adherence to the treatment. Conclusions: The implementation of a NW program is feasible in the public healthcare system and can aid in the management of CVRFs. (C) 2016 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:537 / 539
页数:3
相关论文
共 50 条
  • [31] The Association of Dysglycaemia and Cardiovascular Disease in Patients with Metabolic Syndrome
    Gong, W.
    Yang, Z.
    Ye, W.
    Du, Y.
    Lu, B.
    Wang, M.
    Li, Q.
    Zhang, W.
    Pan, Y.
    Feng, X.
    Zhou, W.
    Zhang, Y.
    Wen, J.
    Yang, Z.
    Yang, Y.
    Zhu, X.
    Hu, R.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (05) : 1486 - 1492
  • [32] The role of walking in the prevention of cardiovascular disease in women
    Manson, JE
    RichEdwards, JW
    Colditz, GA
    Stampfer, MJ
    Willett, WC
    Speizer, FE
    Hennekens, CH
    CIRCULATION, 1996, 94 (08) : 1973 - 1973
  • [33] Walking: the first steps in cardiovascular disease prevention
    Murtagh, Elaine M.
    Murphy, Marie H.
    Boone-Heinonen, Janne
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (05) : 490 - 496
  • [34] Management of ischaemic heart disease in diabetic patients - Is there a role for cardiac metabolic agents?
    Marzilli, M
    CURRENT MEDICAL RESEARCH AND OPINION, 2001, 17 (03) : 153 - 158
  • [35] Metabolic syndrome and cardiovascular disease
    Qiao, Qing
    Gao, Weiguo
    Zhang, Lei
    Nyamdorj, Regzedmaa
    Tuomilehto, Jaakko
    ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 232 - 263
  • [36] Effect of nordic walking on risk factors for cardiovascular disease in people with haemophilia
    Belev, J.
    Marinic, M.
    Boban, A.
    HAEMOPHILIA, 2024, 30 : 30 - 30
  • [37] The metabolic syndrome and cardiovascular disease
    Vitarius, JA
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (04): : 257 - 262
  • [38] Effectiveness of an intervention in cardiovascular prevention for patients with metabolic syndrome: Metbay Proyect
    Madueno Caro, A. J.
    Guija Villa, E.
    Peculo Carrasco, J. A.
    Luque Barea, A.
    Ballester, M.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 97S - 97S
  • [39] The metabolic syndrome and cardiovascular disease
    Bonora, E
    ANNALS OF MEDICINE, 2006, 38 (01) : 64 - 80
  • [40] Prevention of ischaemic events in patients with peripheral arterial disease according to the European guidelines on cardiovascular disease prevention in clinical practice
    Blinc, A.
    Kozak, M.
    Sabovic, M.
    Bozic, M.
    Stegnar, M.
    Poredos, P.
    Kravos, A.
    Zagar, B. Barbic
    Perme, M. Pohar
    Stare, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 509 - 510